“…This may include histamine, generated from mast cells or basophils, as thioperamide, a non-selective blocker of the histamine 3- and 4-receptor, inhibited eosinophil infiltration to the esophagus in an allergen-inhalation model of EoE in guinea pigs. 89 In addition PGD2, a prostanoid largely produced by mast cells, is sufficient to drive eosinophils to the esophagus since injection of a PGD2 agonist into the esophagus led to rapid recruitment of eosinophils in guinea pigs, and pretreatment with a selective antagonist limited this experimental EoE-like disease. 90 Also, in adults with corticosteroid-resistant EoE, treatment for 8 weeks with OC000459, a selective antagonist of CRTH2, the receptor for PGD2, led to reduced tissue eosinophilia and clinical symptoms.…”